New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
12:34 EDTAYI, REGN, TWTR, STAA, FOLD, NFLX, SNYOn The Fly: Midday Wrap
Stocks on Wall Street were sharply higher at midday in the first trading day of the month and the new quarter. The market has not had such a good start to the second half of a year since 2011. The day’s domestic economic data was generally in-line with expectations, while reports from abroad confirmed that manufacturing expanded last month in China and in the eurozone. ECONOMIC EVENTS: In the U.S., two separate manufacturing readings were released. Markit's manufacturing purchasing manager's index for June had a final reading of 57.3, which was a hair below the 57.5 flash estimate but up from May's 56.4 reading. ISM's manufacturing index slipped very slightly to 55.3 in June from May's 55.4 figure. Construction spending increased 0.1% in May, missing the forecast for 0.5% growth. In China, the purchasing manager's index reading from HSBC and Markit came in at 50.7, which was a bit below the preliminary reading but above the 50 mark that indicates expansion for the first time since December. In Europe, Markit's final eurozone manufacturing PMI for June came in at 51.8, which was down from 52.2 in the prior month and below the earlier flash estimate of 51.9, but still indicated expansion in the sector. COMPANY NEWS: Shares of Netflix (NFLX) climbed 6% after Goldman Sachs upgraded the stock in a note to investors earlier today, predicting that Netflix's total worldwide market will more than double over the next three years and its subscriber growth will continue to exceed expectations... Twitter (TWTR) rose more than 4% after hiring Anthony Noto as its new Chief Financial Officer away from Goldman Sachs (GS), which had handled the social network's IPO. Noto served as a Managing Director in the Technology, Media and Telecom group at Goldman since October 2010 after having served as the CFO of the National Football League previously. MAJOR MOVERS: Among the notable gainers was Amicus Therapeutics (FOLD), which rose 23% following upgrades at Leerink and Janney Capital that came a day after the company provided updates on its potential monotherapy for Fabry patients. Also higher was Regeneron (REGN), which advanced 7% after Sanofi (SNY) disclosed in a regulatory filing that it plans to increase its beneficial ownership stake in its smaller pharmaceutical industry peer to 22.5% from 20.5%. Among the noteworthy losers was STAAR Surgical (STAA), which dropped 18% after it received a warning letter from the FDA following the regulator's inspection of a manufacturing plant. Also lower following its earnings reports was lighting solutions maker Acuity Brands (AYI), which fell 13% after its sales and profits missed expectations. INDEXES: Near midday, the Dow was up 134.80, or 0.8%, to 16,961.40, the Nasdaq was up 50.88, or 1.15%, to 4,459.06, and the S&P 500 was up 13.62, or 0.69%, to 1,973.85.
News For NFLX;TWTR;AYI;FOLD;REGN;SNY;STAA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 14, 2015
11:33 EDTTWTRStocks with call strike movement; TWTR SUNE
Subscribe for More Information
09:34 EDTNFLXActive equity options trading on open
Subscribe for More Information
06:20 EDTNFLXStocks with implied volatility below IV index mean; LNKD NFLX
Subscribe for More Information
May 13, 2015
16:57 EDTNFLXNetflix CCO believes traditional TV will shift towards event coverage, BI says
Netflix Chief Content Officer Ted Sarandos believes that as over-the-top TV services gain momentum, traditional cable and satellite TV is going to become "more about events, and more about award shows and live sports," reports Business Insider, citing remarks at a New York media conference. "Where the attribute really is the liveness of it, television is fantastic. And I think the real saving grace for television is they’ll focus on the other things and make it more event-oriented," said Sarandos. Reference Link
12:01 EDTTWTRStocks with call strike movement; TWTR RIG
Subscribe for More Information
09:39 EDTNFLX, TWTRActive equity options trading on open
Subscribe for More Information
07:31 EDTSNYHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
07:16 EDTNFLXMoffett Nathanson to hold a summit
Subscribe for More Information
07:05 EDTSNYSanofi exercises option on therapeutic program with Selecta Biosciences
Selecta Biosciences., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies, today announced that, under the terms of an existing strategic global collaboration, Sanofi has exercised its option to an exclusive license to develop an immunotherapy for the treatment of celiac disease. Under the terms of the collaboration, Selecta is eligible to receive research support and several pre-clinical, clinical, regulatory and sales milestones totaling up to $300 million for this new program in celiac disease. Additionally, Selecta is also entitled to up to double digit tiered royalties as percentage of product net sales for any commercialized immunotherapy resulting from these efforts with Sanofi. November 2012, Selecta announced that they had formed a strategic global collaboration to discover highly targeted, antigen-specific immunotherapies for life threatening allergies. Under the agreement, Sanofi obtained a first exclusive license to develop an immunotherapy designed to abate acute immune responses against a life threatening food allergen and an option to develop two additional candidate immunotherapies for allergies and celiac disease. With the exercise of this option by Sanofi, Selecta and Sanofi now have two initiatives actively advancing immune tolerance treatments under the terms of the 2012 agreement. In October 2014, Selecta and JDRF announced another collaboration with Sanofi to research novel antigen-specific immune therapies for Type 1 Diabetes.
06:55 EDTNFLXInsiders speculate bidding war to erupt over AOL, Business Insider reports
The consensus speculation from investment bankers, hedge fund traders and people close to AOL (AOL) is that another company will emerge and offer a price for AOL that is higher than $50 per share, reports Business Insider. The potential suitors include Time Warner (TWX), Comcast (CMCSA), Yahoo (YHOO), Alibaba (BABA), Softbank (SFTBF), AT&T (T), Netflix (NFLX) and Apple (AAPL). Reference Link
06:50 EDTAYIAcuity Brands price target raised to $207 from $194 at Piper Jaffray
Piper Jaffray raised its price target for Acuity Brands to $207 saying its seeing "positive and steady" improvement in several lighting end markets. Piper expects further market share gains to drive shares higher and keeps an Overweight rating on Acuity.
May 12, 2015
16:01 EDTTWTROptions Update; May 12, 2015
Subscribe for More Information
11:37 EDTTWTRStocks with call strike movement; TWTR JCP
Subscribe for More Information
09:38 EDTNFLX, TWTRActive equity options trading on open
Subscribe for More Information
08:07 EDTNFLXSunTrust to hold a conference
Subscribe for More Information
06:09 EDTTWTRTwitter spent over $85M to buy Periscope, Niche, Re/code reports
Twitter paid over $86M to buy Periscope, a live streaming app, and Niche, a social media talent agency, earlier this year, Re/code reports. Re/code previously said Twitter acquired Niche for approximately $30M, including earn-out payments. Reference Link
06:02 EDTNFLXStocks with implied volatility below IV index mean; LNKD NFLX
Subscribe for More Information
May 11, 2015
16:00 EDTNFLX, TWTROptions Update; May 11, 2015
Subscribe for More Information
11:23 EDTTWTRStocks with call strike movement; TWTR TSLS
Subscribe for More Information
06:33 EDTNFLXTV networks worried amid tough competition from digital outlets, NY Times says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use